Treatment-resistant depression challenges even the most seasoned clinicians. When standard first- and second-line antidepressants fail, successful outcomes require sophisticated clinical reasoning, advanced diagnostic clarity, and systematic interventions. Difficult-to-Treat Depression: A Carlat Guide bridges research evidence and practical clinical decision-making.

Author Dr. Chris Aiken reframes chronic refractory depression as a long-term condition requiring multidimensional management, offering clinicians a reliable roadmap from reassessment to wellness.

Inside the Guide:

• Beyond Standard TRD: Moving past narrow definitions to manage complex, recurrent, and comorbid mood disorders.
• Diagnostic Reassessment: Unmasking bipolar spectrum features, vascular depression, inflammatory subtypes, personality factors, and occult medical conditions.
• Advanced Pharmacotherapy & Augmentation: Evidence-backed augmentation protocols (lithium, pramipexole, thyroid hormone, stimulants, celecoxib) and rapid-acting therapies (ketamine, esketamine, zuranolone).
• Neuromodulation & Somatic Treatments: Clinical indications and protocols for TMS and ECT.
• Deprescribing Strategies: Safely tapering ineffective polypharmacy, extra antidepressants, and sedatives.
• Bonus Material: Includes the companion CME Questions assessment document.